Short-term continuous-flow ventricular assist devices

Hiroo Takayama, Koji Takeda, Darshan Doshi, Ulrich P. Jorde

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: To provide a comprehensive update on the current state of short-term, continuous-flow ventricular assist devices (CF-VADs) in the treatment of refractory cardiogenic shock in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients. RECENT FINDINGS: The mortality rate associated with refractory cardiogenic shock remains markedly elevated, with INTERMACS 1 profile repeatedly demonstrating the worst outcomes. Recent innovations in continuous-flow pump technology have not only contributed to improved outcomes with long-term left ventricular assist device technology, but have also led to the development of various short-term, percutaneous, and surgical CF-VADs. Short-term CF-VADs have several favorable features, but, most notably, they allow the effective temporary stabilization of otherwise refractory cardiogenic shock and serve as a bridge-to-decision therapy. SUMMARY: Clinical evidence supporting the use of CF-VADs still remains at the level of small case series, but the data appear promising. However, further rigorous clinical investigation is necessary in order to prove the overall clinical efficacy of these devices in refractory cardiogenic shock.

Original languageEnglish (US)
Pages (from-to)266-274
Number of pages9
JournalCurrent Opinion in Cardiology
Volume29
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Heart-Assist Devices
Cardiogenic Shock
Registries
Technology
Equipment and Supplies
Mortality
Therapeutics

Keywords

  • cardiogenic shock
  • CentriMag
  • Impella
  • short-term VAD
  • TandemHeart

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Short-term continuous-flow ventricular assist devices. / Takayama, Hiroo; Takeda, Koji; Doshi, Darshan; Jorde, Ulrich P.

In: Current Opinion in Cardiology, Vol. 29, No. 3, 2014, p. 266-274.

Research output: Contribution to journalArticle

Takayama, Hiroo ; Takeda, Koji ; Doshi, Darshan ; Jorde, Ulrich P. / Short-term continuous-flow ventricular assist devices. In: Current Opinion in Cardiology. 2014 ; Vol. 29, No. 3. pp. 266-274.
@article{021c89dc73ec44408da2d89700001628,
title = "Short-term continuous-flow ventricular assist devices",
abstract = "PURPOSE OF REVIEW: To provide a comprehensive update on the current state of short-term, continuous-flow ventricular assist devices (CF-VADs) in the treatment of refractory cardiogenic shock in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients. RECENT FINDINGS: The mortality rate associated with refractory cardiogenic shock remains markedly elevated, with INTERMACS 1 profile repeatedly demonstrating the worst outcomes. Recent innovations in continuous-flow pump technology have not only contributed to improved outcomes with long-term left ventricular assist device technology, but have also led to the development of various short-term, percutaneous, and surgical CF-VADs. Short-term CF-VADs have several favorable features, but, most notably, they allow the effective temporary stabilization of otherwise refractory cardiogenic shock and serve as a bridge-to-decision therapy. SUMMARY: Clinical evidence supporting the use of CF-VADs still remains at the level of small case series, but the data appear promising. However, further rigorous clinical investigation is necessary in order to prove the overall clinical efficacy of these devices in refractory cardiogenic shock.",
keywords = "cardiogenic shock, CentriMag, Impella, short-term VAD, TandemHeart",
author = "Hiroo Takayama and Koji Takeda and Darshan Doshi and Jorde, {Ulrich P.}",
year = "2014",
doi = "10.1097/HCO.0000000000000060",
language = "English (US)",
volume = "29",
pages = "266--274",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Short-term continuous-flow ventricular assist devices

AU - Takayama, Hiroo

AU - Takeda, Koji

AU - Doshi, Darshan

AU - Jorde, Ulrich P.

PY - 2014

Y1 - 2014

N2 - PURPOSE OF REVIEW: To provide a comprehensive update on the current state of short-term, continuous-flow ventricular assist devices (CF-VADs) in the treatment of refractory cardiogenic shock in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients. RECENT FINDINGS: The mortality rate associated with refractory cardiogenic shock remains markedly elevated, with INTERMACS 1 profile repeatedly demonstrating the worst outcomes. Recent innovations in continuous-flow pump technology have not only contributed to improved outcomes with long-term left ventricular assist device technology, but have also led to the development of various short-term, percutaneous, and surgical CF-VADs. Short-term CF-VADs have several favorable features, but, most notably, they allow the effective temporary stabilization of otherwise refractory cardiogenic shock and serve as a bridge-to-decision therapy. SUMMARY: Clinical evidence supporting the use of CF-VADs still remains at the level of small case series, but the data appear promising. However, further rigorous clinical investigation is necessary in order to prove the overall clinical efficacy of these devices in refractory cardiogenic shock.

AB - PURPOSE OF REVIEW: To provide a comprehensive update on the current state of short-term, continuous-flow ventricular assist devices (CF-VADs) in the treatment of refractory cardiogenic shock in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients. RECENT FINDINGS: The mortality rate associated with refractory cardiogenic shock remains markedly elevated, with INTERMACS 1 profile repeatedly demonstrating the worst outcomes. Recent innovations in continuous-flow pump technology have not only contributed to improved outcomes with long-term left ventricular assist device technology, but have also led to the development of various short-term, percutaneous, and surgical CF-VADs. Short-term CF-VADs have several favorable features, but, most notably, they allow the effective temporary stabilization of otherwise refractory cardiogenic shock and serve as a bridge-to-decision therapy. SUMMARY: Clinical evidence supporting the use of CF-VADs still remains at the level of small case series, but the data appear promising. However, further rigorous clinical investigation is necessary in order to prove the overall clinical efficacy of these devices in refractory cardiogenic shock.

KW - cardiogenic shock

KW - CentriMag

KW - Impella

KW - short-term VAD

KW - TandemHeart

UR - http://www.scopus.com/inward/record.url?scp=84899471625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899471625&partnerID=8YFLogxK

U2 - 10.1097/HCO.0000000000000060

DO - 10.1097/HCO.0000000000000060

M3 - Article

C2 - 24694385

AN - SCOPUS:84899471625

VL - 29

SP - 266

EP - 274

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 3

ER -